Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N,N-dimethylglycine sodium salt prevents human dermal papilla senescence and promotes hair growth in patients with pattern hair loss.

Journal of dermatological science·2026
Same author

Integration to "Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines".

Italian journal of dermatology and venereology·2026
Same author

Annular Lichen Planus of the Penis Successfully Treated with Topical Tacrolimus 0.1% Ointment: A Case Report and Systematic Review of the Literature.

Life (Basel, Switzerland)·2026
Same author

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

American journal of clinical dermatology·2026
Same author

Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy.

Clinics and practice·2026
Same author

Standardizing the Management of Alopecia Areata: Results from a Delphi Panel of Italian Experts.

Skin appendage disorders·2026

Related Experiment Video

Updated: Dec 17, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.3K

Dermatologic management of oncotherapy side effects: A proposed algorithm.

Marta Carlesimo1, Flavia Pigliacelli1, Andrea D'Arino1

  • 1Department of Internal Medicine and Medical Specialties, UOC Dermatology, Sapienza University of Rome, Rome, Italy.

Journal of Cosmetic Dermatology
|June 26, 2020
PubMed
Summary

Managing skin side effects from cancer treatments is crucial for patient well-being and treatment success. This study proposes a three-step skin care algorithm to mitigate adverse cutaneous events during oncological therapy.

Keywords:
cosmetologic algorithmoncologic patientskin reactions

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.9K
Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
06:21

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model

Published on: May 27, 2016

8.5K

Related Experiment Videos

Last Updated: Dec 17, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.3K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.9K
Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
06:21

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model

Published on: May 27, 2016

8.5K

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Hundreds of cancer treatments exist, with newer targeted therapies and immunotherapies increasing in specificity.
  • Cutaneous side effects are common with both traditional chemotherapy and novel targeted cancer drugs.
  • Managing these skin toxicities is vital for treatment adherence and patient quality of life.

Purpose of the Study:

  • To propose a structured management algorithm for cutaneous adverse events during oncological treatment.
  • To emphasize the role of proactive and reactive skin care in mitigating treatment-induced dermatologic toxicities.
  • To improve patient outcomes and reduce treatment interruptions caused by skin side effects.

Main Methods:

  • Development of a three-step management algorithm for skin care.
  • Algorithm integrates measures before, during, and after oncological treatments.
  • Focus on practical skin care recommendations to limit or reduce side effect severity.

Main Results:

  • The proposed algorithm provides a systematic approach to managing skin toxicities.
  • Implementation of specific skin care measures can significantly reduce the incidence and severity of cutaneous adverse events.
  • Effective management can prevent dose reductions or treatment suspensions due to skin issues.

Conclusions:

  • A structured, multi-step skin care algorithm is essential for managing cancer treatment-related skin side effects.
  • Proactive skin care before, during, and after therapy is key to optimizing treatment outcomes and patient comfort.
  • This approach supports the continuation of oncological treatments and improves the patient's overall experience.